Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3440753 | 0.87 | — | — | |
| SCHEMBL2800934 | 0.84 | — | — | |
| SCHEMBL2803719 | 0.80 | — | — | |
| SCHEMBL2803810 | 0.78 | ALDH1A1 (0.50) | ALDH1A1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL7867524 | 0.77 | — | — | |
| SCHEMBL16774607 | 0.77 | ALDH1A1 (0.54) | ALDH1A1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL9017115 | 0.77 | ALDH1A1 (0.54) | ALDH1A1TDP1TSHRSMN1; SMN2 | |
| SCHEMBL1176570 | 0.73 | LMNA (0.33) | — | |
| SCHEMBL3762623 | 0.73 | ALDH1A1 (0.42) | ALDH1A1TDP1TSHRTP53HBB | |
| SCHEMBL3440786 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2357180-A1 | Manufacture of epoxyethyl ethers or glycidyl ethers | Momentive Specialty Chemicals Research Belgium S.A. (BE) | 2011-08-17 | — | — | EP | claimed |
| EP-2531497-B1 | Manufacture of epoxyethyl ethers or glycidyl ethers | HEXION RES BELGIUM SA (BE) | 2016-09-07 | — | — | EP | disclosed |
| US-9145378-B2 | Manufacture of an epoxyethyl ethers or glycidyl ethers | HEXION INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20120330041-A1 | MANUFACTURE OF AN EPOXYETHYL ETHERS OR GLYCIDYL ETHERS | Westlake Epoxy Inc. | 2012-12-27 | — | — | US | disclosed |
| EP-2357180-A1 | Manufacture of epoxyethyl ethers or glycidyl ethers | Momentive Specialty Chemicals Research Belgium S.A. (BE) | 2011-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120330041-A1 | MANUFACTURE OF AN EPOXYETHYL ETHERS OR GLYCIDYL ETHERS | TET2, MLX, LOX | ALDH1A1 3230/4885TDP1 4721/4885TSHR 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.